New Jersey · 2026-2027 Regular Session · Bill

A 4699: Requires health insurance carriers to cover genetic testing after diagnosis of pancreatic cancer.

In committee Last action March 16, 2026: Introduced, Referred to Assembly Financial Institutions and Insurance Committee

Plain-language summary

A 4699 is a bill introduced in the New Jersey House on March 16, 2026. According to its official title, it concerns: Requires health insurance carriers to cover genetic testing after diagnosis of pancreatic cancer. Primary sponsor: Shanique Speight (Democratic), Sterley Stanley (Democratic), Donlon, Margie, M.D.. Most recent recorded action (March 16, 2026): Introduced, Referred to Assembly Financial Institutions and Insurance Committee.

Sponsors

Primary sponsors: Shanique Speight (Democratic); Sterley Stanley (Democratic); Donlon, Margie, M.D..